Get an alert when ALEXION PHARMA UK LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£15k

+503,733.3% vs 2024

Net assets

£9.3m

+66.9% vs 2024

Employees

73

-2.7% lowest in 3 filed years

Profit before tax

£5m

-21.6% lowest in 3 filed years

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover £115,085,381£122,845,851£102,267,281 -16.8%
Operating profit £5,576,279£5,886,077£4,854,791 -17.5%
Profit before tax £6,458,282£6,369,682£4,993,717 -21.6%
Net profit £4,814,854£4,656,096£3,746,184 -19.5%
Cash £15,125£3£15,115 +503,733.3%
Total assets less current liabilities £15,943,999£5,600,095£14,312,911 +155.6%
Net assets £15,943,999£5,600,095£9,346,279 +66.9%
Equity £15,943,999£5,600,095£9,346,279 +66.9%
Average employees 817573 -2.7%
Wages £10,913,515£10,963,300£9,304,836 -15.1%
Directors' remuneration £2,431,099£903,597£724,014 -19.9%
Highest paid director £2,431,099£630,416£463,849 -26.4%

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Operating margin 4.8%4.8%4.7%
Net margin 4.2%3.8%3.7%
Return on capital employed 35.0%105.1%33.9%
Gearing (liabilities / total assets) 72.7%83.2%74.8%
Current ratio 1.37x1.20x1.64x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. ALEXION PHARMA UK LIMITED 2006-11-03 → present
  2. PIMCO 2564 LIMITED 2006-10-17 → 2006-11-03

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 18 resigned

Name Role Appointed Born Nationality
OLLE, Francesc Secretary 2025-08-31 — —
ELLOIAN, Michael Ira Kenneth Director 2018-08-03 May 1972 American
OLLE, Francesc Director 2024-04-24 Jun 1987 Spanish
RICHARDS, Deborah Director 2024-04-24 Sep 1967 British
Show 18 resigned officers
Name Role Appointed Resigned
BHALLA, Mayank, Dr Secretary 2024-04-24 2025-09-01
DUFAUX, Philippe Secretary 2017-11-02 2024-02-02
OLLE, Francesc Secretary 2024-02-02 2024-04-18
PINSENT MASONS SECRETARIAL LIMITED Corporate Secretary 2006-10-17 2007-07-24
YORK PLACE COMPANY SECRETARIES LIMITED Corporate Secretary 2007-06-01 2017-11-02
BARRETT, Mark Shane Director 2007-06-01 2014-02-07
COISSAC, Patrice Director 2006-11-16 2009-06-15
DEVEQUE, Pierre Director 2007-09-01 2010-08-03
DUBIN, Thomas I H Director 2009-06-15 2010-08-03
FRAZER, Elaine Director 2016-12-06 2018-06-27
FRYER, Jeffrey Michael Director 2009-06-15 2016-12-06
GRECO, Michael Vincent Director 2010-08-03 2016-12-06
GREER, Vivien Ruth Director 2018-08-03 2022-07-15
KEISER, David Wharton Director 2007-09-01 2009-06-15
RICHARDSON, Sean Barnaby Robert Knox Director 2018-04-17 2024-04-18
TRAFFORD-JONES, Sara Director 2015-11-09 2018-04-17
WOODS, Robert Keith Director 2014-02-07 2015-12-15
PINSENT MASONS DIRECTOR LIMITED Corporate Director 2006-10-17 2006-11-16

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Alexion Pharmaceuticals, Inc. Corporate entity Shares 50–75%, Voting 50–75% 2016-04-06 Active

Filing timeline

Last 20 of 108 total filings

Date Type Category Description
2026-10-08 AA accounts Accounts with accounts type full
2025-11-05 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-10-07 AA accounts Accounts with accounts type full
2025-09-10 CH01 officers Change person director company with change date PDF
2025-09-05 CH01 officers Change person director company with change date PDF
2025-09-05 AP03 officers Appoint person secretary company with name date PDF
2025-09-05 TM02 officers Termination secretary company with name termination date PDF
2024-10-29 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-10-11 AA accounts Accounts with accounts type full
2024-04-24 AP03 officers Appoint person secretary company with name date PDF
2024-04-24 AP01 officers Appoint person director company with name date PDF
2024-04-24 AP01 officers Appoint person director company with name date PDF
2024-04-23 TM01 officers Termination director company with name termination date PDF
2024-04-23 TM02 officers Termination secretary company with name termination date PDF
2024-02-19 AD01 address Change registered office address company with date old address new address PDF
2024-02-02 AP03 officers Appoint person secretary company with name date PDF
2024-02-02 TM02 officers Termination secretary company with name termination date PDF
2023-10-30 AA accounts Accounts with accounts type full
2023-10-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-11-03 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page

Spotted an error, or named here and want to reply? Report it · How we handle corrections